课题基金 / 基金详情

NIDDM PRIMARY PREVENTION TRIAL

NIDDM PRIMARY PREVENTION TRIAL
NIDDM 一级预防试验
批准号：
6303700
负责人：
DINESH KUMAR
金额：
$3.56万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
项目状态：
已结题
起止时间：
1999-12-01 至 2000-11-30
来源：
https://reporter.nih.gov/project-details/6303700
关键词：
behavior modification behavioral /social science research tag clinical research diabetes mellitus therapy disease /disorder prevention /control disease /disorder proneness /risk human subject human therapy evaluation medical complication noninsulin dependent diabetes mellitus

项目摘要

项目成果

DINESH KUMAR的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cellcept or Mycophenolate is an immunosuppresive drug which blocks the phosphoralation of inositol to convert it to guanidine. Already used in renal and liver transplants in adults, this study will evaluate the safety and efficacy of the drug in children who will undergo renal transplant. The primary efficacy endpoint is the proportion of patients with a rejection episode in the first 6 months.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIDDM PRIMARY PREVENTION TRIAL
NIDDM PRIMARY PREVENTION TRIAL
NIDDM PRIMARY PREVENTION TRIAL